APA (7th ed.) Citation

SK, M., P, K., MCW, W., B, A., JS, G., M, D., . . . IM, S. (2023). First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer. Frontiers in immunology, 14, 1122977. https://doi.org/10.3389/fimmu.2023.1122977

Chicago Style (17th ed.) Citation

SK, Mørk, et al. "First in Man Study: Bcl-Xl_42-CAF®09b Vaccines in Patients with Locally Advanced Prostate Cancer." Frontiers in Immunology 14 (2023): 1122977. https://doi.org/10.3389/fimmu.2023.1122977.

MLA (9th ed.) Citation

SK, Mørk, et al. "First in Man Study: Bcl-Xl_42-CAF®09b Vaccines in Patients with Locally Advanced Prostate Cancer." Frontiers in Immunology, vol. 14, 2023, p. 1122977, https://doi.org/10.3389/fimmu.2023.1122977.